{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T18:31:45Z","timestamp":1648665105327},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med.","J. Jpn. Soc. Intern. Med"],"published-print":{"date-parts":[[2011]]},"DOI":"10.2169\/naika.100.2942","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T23:10:31Z","timestamp":1365549031000},"page":"2942-2947","source":"Crossref","is-referenced-by-count":0,"title":["7. Cyclosporine"],"prefix":"10.2169","volume":"100","author":[{"given":"Ken","family":"Yamaji","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Faulds D, et al: Cyclosporine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 45: 953-1040, 1993.","DOI":"10.2165\/00003495-199345060-00007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tsujimura S, et al: Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes. Genes Cells 9: 1265-1273, 2004.","DOI":"10.1111\/j.1365-2443.2004.00803.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Yocum DE, Torley H: Cyclosporine in rheumatoid arthritis. Rheum Dis Clin North Am 21: 835-844, 1995.","DOI":"10.1016\/S0889-857X(21)00470-1"},{"key":"4","unstructured":"4) Cush JJ, et al: US consensus guidelines for the usage of cyclosporine A in rheumatoid arthritis. J Rheumatol 26: 1176-1186, 1999."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Gerards AH, et al: Cyclosporin A monotherapy versus cyclosporine A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomized placebo controlled trial. Ann Rheum Dis 62: 291-296, 2003.","DOI":"10.1136\/ard.62.4.291"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Marchesoni A, et al: Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporine and methotrexate with methotrexate alone. Rheumatology 42: 1545-1549, 2003.","DOI":"10.1093\/rheumatology\/keg394"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Moroni G, et al: A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clin J Am Soc Nephrol 1: 925-932, 2006.","DOI":"10.2215\/CJN.02271205"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Austin HA 3rd, et al: Randomized, controlled trial of prednisolone, cyclophosphamide, and cyclosporine in lupus membrane nephropathy. Am J Soc Nephrol 20: 901-911, 2009.","DOI":"10.1681\/ASN.2008060665"},{"key":"9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Griffiths B, et al: The BILAG multi-center open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE. Rheumatology 49: 723-732, 2010.","DOI":"10.1093\/rheumatology\/kep396"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Vencovsky J, et al: Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis. Scand J Rheumatol 29 (2): 95-102, 2000.","DOI":"10.1080\/030097400750001897"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Corderio AC, Isenberg DA: Treatment of inflammatory myopathies. Postgrad Med J 82: 417-424, 2006.","DOI":"10.1136\/pgmj.2005.038455"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nagasaka K, et al: Efficacy of combination treatment with cyclosporine and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis. Mod Rheumatology 13: 231-238, 2003.","DOI":"10.3109\/s10165-003-0205-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Takada K, et al: Step-up versus primary intensive approach to the treatment of interstitial pneumonia associated with dermatomyositis\/polymyositis: a retrospective study. Modern Rheumatology 17: 123-130, 2007.","DOI":"10.3109\/s10165-007-0553-3"},{"key":"15","unstructured":"15) BenEzra D, et al: Evaluation of conventional therapy versus cyclosporine A in Behcet's syndrome. Transplant Proc 20: 136-143, 1988."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kotter I, et al: CNS involvement occurs more frequently in patients with Behcet's disease under cyclosporine A than under other medications-results of a retrospective analysis of 117 cases. Clin Rheumatol 25: 482-486, 2006.","DOI":"10.1007\/s10067-005-0070-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Hot A, et al: Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long term outcome: a case control study of 8 patients. Medicine 89: 37-46, 2010.","DOI":"10.1097\/MD.0b013e3181caf100"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/100\/10\/100_2942\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T11:58:35Z","timestamp":1644753515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/100\/10\/100_2942\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.100.2942","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}